AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
Aminopeptidase A inhibitors
Authors: David-Basei, C Fournie-Zaluski, MC Rogues, BP
Citation: C. David-basei et al., Aminopeptidase A inhibitors, EXPERT OP T, 11(3), 2001, pp. 431-444
Angiotensin III: a central regulator of vasopressin release and blood pressure
Authors: Reaux, A Fournie-Zaluski, MC Llorens-Cortes, C
Citation: A. Reaux et al., Angiotensin III: a central regulator of vasopressin release and blood pressure, TRENDS ENDO, 12(4), 2001, pp. 157-162
Delta(9)-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect
Authors: Valverde, O Noble, F Beslot, F Dauge, V Fournie-Zaluski, MC Roques, BP
Citation: O. Valverde et al., Delta(9)-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect, EUR J NEURO, 13(9), 2001, pp. 1816-1824
Synthesis of [3(R)-amino-2(S)-sulfhydryl-5-sulfonate]-pentanoyl-(S)-3-[I-125]-iodotyrosyl-(S)-aspartic acid: a radiolabelled inhibitor of aminopeptidase A
Authors: David-Basei, C Bischoff, L Fournie-Zaluski, MC Roques, BP
Citation: C. David-basei et al., Synthesis of [3(R)-amino-2(S)-sulfhydryl-5-sulfonate]-pentanoyl-(S)-3-[I-125]-iodotyrosyl-(S)-aspartic acid: a radiolabelled inhibitor of aminopeptidase A, J LABEL C R, 44(1), 2001, pp. 89-98
First discrete autoradiographic distribution of aminopeptidase N in various structures of rat brain and spinal cord using the selective iodinated inhibitor [I-125]RB 129
Authors: Noble, F Banisadr, G Jardinaud, F Popovici, T Lai-Kuen, R Chen, H Bischoff, L Parsadaniantz, SM Fournie-Zaluski, MC Roques, BP
Citation: F. Noble et al., First discrete autoradiographic distribution of aminopeptidase N in various structures of rat brain and spinal cord using the selective iodinated inhibitor [I-125]RB 129, NEUROSCIENC, 105(2), 2001, pp. 479-488
Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration
Authors: Boudinot, E Morin-Surun, MP Foutz, AS Fournie-Zaluski, MC Roques, BP Denavit-Saubie, M
Citation: E. Boudinot et al., Effects of the potent analgesic enkephalin-catabolizing enzyme inhibitors RB101 and kelatorphan on respiration, PAIN, 90(1-2), 2001, pp. 7-13
Intramolecular chelation of Zn2+ by alpha- and beta-mercaptocarboxamides. A parallel ab initio and polarizable molecular mechanics investigation. assessment of the role of multipole transferability
Authors: Tiraboschi, G Fournie-Zaluski, MC Roques, BP Gresh, N
Citation: G. Tiraboschi et al., Intramolecular chelation of Zn2+ by alpha- and beta-mercaptocarboxamides. A parallel ab initio and polarizable molecular mechanics investigation. assessment of the role of multipole transferability, J COMPUT CH, 22(10), 2001, pp. 1038-1047
Facilitation of enkephalins catabolism inhibitor-induced antinociception by drugs classically used in pain management
Authors: Nieto, MM Wilson, J Walker, J Benavides, J Fournie-Zaluski, MC Roques, BP Noble, F
Citation: Mm. Nieto et al., Facilitation of enkephalins catabolism inhibitor-induced antinociception by drugs classically used in pain management, NEUROPHARM, 41(4), 2001, pp. 496-506
Long lasting antinociceptive properties of enkephalin degrading enzyme (NEP and APN) inhibitor prodrugs
Authors: Chen, HX Noble, F Roques, BP Fournie-Zaluski, MC
Citation: Hx. Chen et al., Long lasting antinociceptive properties of enkephalin degrading enzyme (NEP and APN) inhibitor prodrugs, J MED CHEM, 44(21), 2001, pp. 3523-3530
Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat
Authors: Arbin, V Claperon, N Fournie-Zaluski, MC Roques, BP Peyroux, J
Citation: V. Arbin et al., Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat, BR J PHARM, 133(4), 2001, pp. 495-502
Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabeticrats
Authors: Coudore-Civiale, MA Meen, M Fournie-Zaluski, MC Boucher, M Roques, BP Eschalier, A
Citation: Ma. Coudore-civiale et al., Enhancement of the effects of a complete inhibitor of enkephalin-catabolizing enzymes, RB 101, by a cholecystokinin-B receptor antagonist in diabeticrats, BR J PHARM, 133(1), 2001, pp. 179-185
Exploration of the S-1 ' subsite of neprilysin: A joined molecular modeling and site-directed mutagenesis study
Authors: Marie-Claire, C Tiraboschi, G Ruffet, E Inguimbert, N Fournie-Zaluski, MC Roques, BP
Citation: C. Marie-claire et al., Exploration of the S-1 ' subsite of neprilysin: A joined molecular modeling and site-directed mutagenesis study, PROTEINS, 39(4), 2000, pp. 365-371
Synthesis of 2(S)-benzyl-3-[hydroxy(1 '(R)-amino ethyl)phosphinyl]propanoyl-L-3-[I-125]-iodotyrosine: A radiolabelled inhibitor of aminopeptidase N
Authors: Chen, HX Bischoff, L Fournie-Zaluski, MC Roques, BP
Citation: Hx. Chen et al., Synthesis of 2(S)-benzyl-3-[hydroxy(1 '(R)-amino ethyl)phosphinyl]propanoyl-L-3-[I-125]-iodotyrosine: A radiolabelled inhibitor of aminopeptidase N, J LABEL C R, 43(2), 2000, pp. 103-111
Aminopeptidase A, which generates one of the main effector peptides of thebrain renin-angiotensin system, angiotensin III, has a key role in centralcontrol of arterial blood pressure
Authors: Reaux, A Iturrioz, X Vazeux, G Fournie-Zaluski, MC David, C Roques, BP Corvol, P Llorens-Cortes, C
Citation: A. Reaux et al., Aminopeptidase A, which generates one of the main effector peptides of thebrain renin-angiotensin system, angiotensin III, has a key role in centralcontrol of arterial blood pressure, BIOCH SOC T, 28, 2000, pp. 435-440
Mechanism of action of clostridial neurotoxins and rational inhibitor design
Authors: Roques, BP Anne, C Turcaud, S Fournie-Zaluski, MC
Citation: Bp. Roques et al., Mechanism of action of clostridial neurotoxins and rational inhibitor design, BIO CELL, 92(6), 2000, pp. 445-447
Straightforward and diastereoselective synthesis of tetrafunctionalized thiol synthons for the design of metallopeptidase inhibitors
Authors: David, C Bischoff, L Roques, BP Fournie-Zaluski, MC
Citation: C. David et al., Straightforward and diastereoselective synthesis of tetrafunctionalized thiol synthons for the design of metallopeptidase inhibitors, TETRAHEDRON, 56(2), 2000, pp. 209-215
Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors:Synthesis, biological properties, and antinociceptive activities
Authors: Chen, HX Noble, F Mothe, A Meudal, H Coric, P Danascimento, S Roques, BP George, P Fournie-Zaluski, MC
Citation: Hx. Chen et al., Phosphinic derivatives as new dual enkephalin-degrading enzyme inhibitors:Synthesis, biological properties, and antinociceptive activities, J MED CHEM, 43(7), 2000, pp. 1398-1408
Binding properties of a highly potent and selective iodinated aminopeptidase N inhibitor appropriate for radioautography
Authors: Noble, F Luciani, N Da Nascimento, S Lai-Kuen, R Bischoff, L Chen, HX Fournie-Zaluski, MC Roques, BP
Citation: F. Noble et al., Binding properties of a highly potent and selective iodinated aminopeptidase N inhibitor appropriate for radioautography, FEBS LETTER, 467(1), 2000, pp. 81-86
Analgesic doses of the enkephalin degrading enzyme inhibitor RB 120 do nothave discriminative stimulus properties
Authors: Hutcheson, DM Subhan, F Pache, DM Maldonado, R Fournie-Zaluski, MC Roques, BP Sewell, RDE
Citation: Dm. Hutcheson et al., Analgesic doses of the enkephalin degrading enzyme inhibitor RB 120 do nothave discriminative stimulus properties, EUR J PHARM, 401(2), 2000, pp. 197-204
Effects of combined neutral endopeptidase 24-11 and angiotensin-convertingenzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats
Authors: Arbin, V Claperon, N Fournie-Zaluski, MC Rogues, BP Peyroux, J
Citation: V. Arbin et al., Effects of combined neutral endopeptidase 24-11 and angiotensin-convertingenzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats, BR J PHARM, 130(6), 2000, pp. 1297-1304
Nucleomimetic strategy for the inhibition of HIV-1 nucleocapsid protein NCp7 activities
Authors: Druillennec, S Meudal, H Roques, BP Fournie-Zaluski, MC
Citation: S. Druillennec et al., Nucleomimetic strategy for the inhibition of HIV-1 nucleocapsid protein NCp7 activities, BIOORG MED, 9(4), 1999, pp. 627-632
Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitor
Authors: Chen, HX Roques, BP Fournie-Zaluski, MC
Citation: Hx. Chen et al., Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitor, BIOORG MED, 9(11), 1999, pp. 1511-1516
A three-dimensional construction of the active site (region 507-749) of human neutral endopeptidase (EC.3.4.24.11)
Authors: Tiraboschi, G Jullian, N Thery, V Antonczak, S Fournie-Zaluski, MC Roques, BP
Citation: G. Tiraboschi et al., A three-dimensional construction of the active site (region 507-749) of human neutral endopeptidase (EC.3.4.24.11), PROTEIN ENG, 12(2), 1999, pp. 141-149
Future medication in the management of pain: complete inhibitors of enkephalin catabolism
Authors: Noble, F Fournie-Zaluski, MC Roques, BP
Citation: F. Noble et al., Future medication in the management of pain: complete inhibitors of enkephalin catabolism, THERAPIE, 54(1), 1999, pp. 121-133
PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III
Authors: Reaux, A de Mota, N Zini, S Cadel, S Fournie-Zaluski, MC Roques, BP Corvol, P Llorens-Cortes, C
Citation: A. Reaux et al., PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III, NEUROENDOCR, 69(5), 1999, pp. 370-376
Risultati: 1-25 | 26-33